Inflammation-triggered andrographolide nanoprodrug platform for lung-targeted delivery and immune homeostasis recovery: A therapeutic strategy against cytokine storm.
- DOI
- 10.1016/j.ajps.2026.101200
- Published
- 2026 Oct
- Container
- Asian journal of pharmaceutical sciences
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ajps.2026.101200,
title = {Inflammation-triggered andrographolide nanoprodrug platform for lung-targeted delivery and immune homeostasis recovery: A therapeutic strategy against cytokine storm.},
author = {Zhou Y and Wang J and Chen Y and Li Z and Puras G and Pedraz JL and Gu Z and He Y},
year = {2026},
journal = {Asian journal of pharmaceutical sciences},
doi = {10.1016/j.ajps.2026.101200},
url = {https://doi.org/10.1016/j.ajps.2026.101200}
}RIS
TY - JOUR TI - Inflammation-triggered andrographolide nanoprodrug platform for lung-targeted delivery and immune homeostasis recovery: A therapeutic strategy against cytokine storm. AU - Zhou Y AU - Wang J AU - Chen Y AU - Li Z AU - Puras G AU - Pedraz JL AU - Gu Z AU - He Y PY - 2026 JO - Asian journal of pharmaceutical sciences DO - 10.1016/j.ajps.2026.101200 UR - https://doi.org/10.1016/j.ajps.2026.101200 ER -
APA
Y, Z., J, W., Y, C., Z, L., G, P., JL, P., Z, G., & Y, H. (2026). Inflammation-triggered andrographolide nanoprodrug platform for lung-targeted delivery and immune homeostasis recovery: A therapeutic strategy against cytokine storm.. Asian journal of pharmaceutical sciences. https://doi.org/10.1016/j.ajps.2026.101200
Source records
- pubmed · retrieved 2026-11-10T12:01:50.875Z